Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Alpha lipoic acid (ALA) is a clinically studied antioxidant supplement that may help reduce pain, burning, and numbness while improving nerve conduction in people with peripheral neuropathy. Typical effective doses range from 300 to 600 mg daily, with both oral and intravenous forms showing benefit in research.
However, results depend on several factors, including dosing schedule, timing with meals, potential side effects, drug interactions (especially with diabetes and thyroid medications), and underlying health conditions like diabetes or vitamin deficiencies.
Because neuropathy symptoms can stem from many different causes — and the right treatment depends on identifying the root issue — it's worth taking a few minutes to understand what may be driving your symptoms before starting any supplement. A free, instant, online symptom check can help you clarify possible causes, guide your next steps, and give you confident questions to bring to your doctor.
Reviewed for medical accuracy: 06/22/2026
Burning or tingling feet? 30 seconds to find your next step.
Have you been diagnosed with diabetic neuropathy in your feet?
Peripheral neuropathy—numbness, tingling or burning in the hands and feet—is a common complication of diabetes and other conditions. Alpha lipoic acid (ALA) has emerged as one of the most studied supplements for protecting nerve cells and easing neuropathic symptoms. Here's what you need to know.
Alpha lipoic acid is a naturally occurring compound found in every cell. It acts as a powerful antioxidant, helping to:
Although our bodies make small amounts, supplemental ALA can boost antioxidant defenses and target oxidative stress in peripheral nerves.
Chronic high blood sugar and toxin exposure can damage nerve fibers and their protective insulation (myelin). ALA helps by:
Clinical trials—such as the ALADIN and SYDNEY studies—have demonstrated symptom relief (pain, burning, numbness) with ALA supplementation.
Research into diabetic and chemotherapy-induced neuropathy shows that ALA may:
A 2012 meta-analysis in "Diabetes Research and Clinical Practice" concluded that 600 mg of ALA daily significantly improved neuropathic symptoms over placebo.
Choosing the right dose is critical for safety and effectiveness. Here's what clinical evidence suggests:
Tips for dosing:
Alpha lipoic acid is generally well tolerated. Possible side effects include:
To minimize risks:
ALA may be a good option if you experience:
Contraindications and precautions:
For best results, combine ALA supplementation with:
If you're experiencing numbness, tingling, or burning sensations and want to understand what might be causing your symptoms, you can check your symptoms with a free AI-powered tool to get personalized insights and recommendations on whether you should see a healthcare provider right away.
Always discuss new supplements with your healthcare team—especially if you have serious or life-threatening conditions. Seek prompt medical care if you experience:
Alpha lipoic acid offers a well-researched, antioxidant approach to managing neuropathy. With typical doses of 300–600 mg daily, ALA can ease pain, improve nerve function and support overall nerve health. Always start low, monitor for side effects, and integrate ALA into a comprehensive plan that includes blood sugar control and proper vitamin support.
Speak to your doctor before starting alpha lipoic acid—especially if you're pregnant, nursing, on glucose-lowering medications or have thyroid issues. A healthcare professional can tailor the dosage to your needs and ensure safe, effective use.
(References)
* Rochette L, Ghibu S, Richard C, et al. Alpha-Lipoic Acid as a Neuroprotective Agent: A Narrative Review. Antioxidants (Basel). 2021 Jun 25;10(7):1024. doi: 10.3390/antiox10071024. PMID: 34208398; PMCID: PMC8300227.
* Sun T, Yu J, Cao S, et al. Alpha-lipoic acid in the treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials. BMC Neurol. 2020 May 14;20(1):173. doi: 10.1186/s12883-020-01742-9. PMID: 32410629; PMCID: PMC7225674.
* Li H, Yang M, Li M, et al. Alpha-Lipoic Acid for the Treatment of Peripheral Neuropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2024 Jan 31;16(3):421. doi: 10.3390/nu16030421. PMID: 38317765; PMCID: PMC10857351.
* Woszczyna N, Michalik M, Bajerska J. The role of alpha-lipoic acid (ALA) in the treatment of diabetic polyneuropathy: a systematic review. Nutr Metab (Lond). 2022 Aug 23;19(1):60. doi: 10.1186/s12986-022-00693-0. PMID: 36014494; PMCID: PMC9401736.
* Lazzaro V, Aversa A, Campagnolo M, et al. Alpha-Lipoic Acid for Diabetic Neuropathy and Other Neurological Conditions: A Comprehensive Review. J Clin Med. 2023 Mar 23;12(7):2502. doi: 10.3390/jcm12072502. PMID: 36979603; PMCID: PMC10094770.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.